Frequency and outcomes of concomitant use of proton pump inhibitors and clopidogrel after hospital discharge

Therapie

Volumn 68, Issue 2, 2013, Pages 113-115

  Mas Morey, Pedro ^a   Calderón Hernanz, Beatriz ^a   Oliver Noguera, Aina ^a   Ripoll Vera, Tomàs ^a   Vilanova Boltó, Montserrat ^a  

^a HOSPITAL SON LLÀTZER   (Spain)

Author keywords

Clopidogrel; Drug interactions; Drug safety; Proton pump inhibitors

Indexed keywords

CLOPIDOGREL; PROTON PUMP INHIBITOR;

ARTICLE; CARDIOVASCULAR RISK; CLINICAL TRIAL; FOLLOW UP; HOSPITAL DISCHARGE; HOSPITAL READMISSION; HUMAN; MAJOR CLINICAL STUDY; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY;

EID: 84879344689     PISSN: 00405957     EISSN: 19585578     Source Type: Journal    
DOI: 10.2515/therapie/2013013     Document Type: Article

References (12)

1. Clopidogrel product information. [Spanish version, online]. EMEA. European Medicines Agency. http://www.aemps.gob.es/cima/especialidad.do?metodo= verFichaWordPdf&codigo=71978&formato=pdf&formulario=FICHAS&file= ficha.pdf.
2. Calderón Hernanz B, Pinteño Blanco M, Puigventos Latorre F et al,. Safety and effectiveness of combining clopidogrel and proton pump inhibitors. Farm Hosp 2009; 33 (6): 338-9
3. Calderón Hernanz B, Pinteño Blanco M, Puigventos Latorre F et al,. Controversy regarding the concomitant use of clopidogrel and proton pump inhibitors (PPI). Farm Hosp 2009; 33 (6): 339-40
4. European Medicines Agency. Interaction between clopidogrel and proton-pump inhibitors. Public statement. March 2010. Report n° EMA/174948/2010. http://www.emea.europa.eu/docs/en-GB/document-library/Public- statement/2010/03/WC50
5. O'Donoghue ML, Braunwald E, Antman EM et al,. Pharmacodynamic effect and clinical efficacy of clopidogrel and prasugrel with or without a proton-pump inhibitor: an analysis of two randomised trials. Lancet 2009; 374 (9694): 989-97
6. Juurlink DN, Gomes T, Ko DT et al,. A population-based study of the drug interaction between proton pump inhibitors and clopidogrel. CMAJ 2009; 180 (7): 713-8
7. Kwok CS, Loke YK. Meta-analysis: the effects of proton pump inhibitors on cardiovascular events and mortality in patients receiving clopidogrel. Aliment Pharmacol Ther 2010; 31 (8): 810-23
8. Zairis MN, Tsiaousis GZ, Patsourakos NG et al,. The impact of treatment with omeprazole on the effectiveness of clopidogrel drug therapy during the first year after successful coronary stenting. Can J Cardiol 2010; 26 (2): e54-7
9. Kwok CS, Loke YK. Effects of proton pump inhibitors on platelet function in patients receiving clopidogrel: a systematic review. Drug Saf 2012; 35 (2): 127-39
10. Juel J, Pareek M, Jensen SE. The clopidogrel-PPI interaction: an updated mini-review. Curr Vasc Pharmacol 2012; Oct 17 [Epub ahead of print]
11. Wilffert B, Swen J, Mulder H et al,. From evidence based medicine to mechanism based medicine. Reviewing the role of pharmacogenetics. Int J Clin Pharm 2011; 33: 3-9
12. Ho PM, Maddox TM, Wang L et al,. Risk of adverse outcomes associated with concomitant use of clopidogrel and proton pump inhibitors following acute coronary syndrome. JAMA 2009; 301 (9): 937-44